# Eli Lilly and Company (LLY) — Q1-2021 Earnings Results

**Report date:** 2021-04-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.87 | N/A | -11.92% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concern over the earnings miss but highlighted their commitment to innovation. They are focused on future growth opportunities.

**Key quotes:**

> Management acknowledged challenges in meeting earnings expectations.

> They emphasized ongoing efforts to enhance product pipeline.

> The focus remains on long-term growth despite short-term setbacks.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Eli Lilly's earnings report indicates a shortfall in EPS expectations, which may raise concerns among investors about the company's current performance. The lack of revenue data and guidance updates adds uncertainty to the outlook. The stock reaction is not available, but the earnings miss could lead to cautious sentiment in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2021_